Clinical Trial Update: Pilot Study on Caffeine Efficiency in ADCY5-related Dyskinesia

View source ↗

Summary

A completed pilot trial evaluating caffeine for ADCY5-related dyskinesia. The snippet does not provide efficacy results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adcy5-related Dyskinesia

Drugs mentioned

• Caffeine (caffeine)

Snippet

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France | Conditions: Dyskinesias | Status: COMPLETED